There are 4 papers on miR-106b in aging research: 4 observational studies in people.
4 papers study it2 more mention it1 finding
“A statistical trend towards lower odds of accelerated bone loss with lower serum levels was noted for osteoinhibitory miR-106b (miR-106b: OR 0.65 [0.39-1.08], p=0.098).”
- Humans4
Associations
1Accelerated bone loss
downin humans1OR 0.65
1 study
Accelerated bone loss
downin humans1OR 0.65
miR-106b is associated with accelerated bone loss in humans (adjusted for age) (OR 0.65 [0.39-1.08], p=0.098).
“A statistical trend towards lower odds of accelerated bone loss with lower serum levels was noted for osteoinhibitory miR-106b (miR-106b: OR 0.65 [0.39-1.08], p=0.098).”
Humansadjusted for ageserum5 yearsfemalesn = 139
Osteologie/Osteology
Latest
2 papers in 12 monthsEuropean Journal of Gastroenterology & Hepatology
MicroRNA hepatocellular carcinoma detect: discriminant function based on a circulating panel of microRNA for accurate diagnosis of hepatocellular carcinoma patients on top hepatitis C virus infection
Case-control study of 145 peopleHepatocellular carcinoma
Cellular Reprogramming
Whole Blood Transcriptome Analysis for Lifelong Monitoring in Elite Sniffer Dogs Produced by Somatic Cell Nuclear Transfer
Experiments in animalsBiomarkers